NEW YORK (GenomeWeb) – 14M Genomics today announced a collaboration with the Haematological Malignancy Research Network aimed at improving diagnosis and clinical care for patients with blood and lymphatic cancers.

The project will investigate the effect of genomic variation on clinical outcomes and create a reference database as a resource for the prognosis of cancer patients and to help guide treatment for newly diagnosed patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.